GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Express News | Gamestop's night trading continued to rise by over 13%, up 21% previously.
US stocks close | Three major indexes rise and fall, nvidia rises nearly 5% to create a new closing high.
Chip stocks experienced a thrilling three-day reversal. Nvidia ended its two-day decline, while AMD fell by 2%. Apple rose for the sixth consecutive day, while Gamestop rose 75% at the opening and closed with a 21% gain.
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
On Monday, Structure Therapeutics Inc. (NASDAQ:GPCR) revealed 12-week topline obesity data from its Phase 2a study of GSBR-1290.In the Phase 2a obesity study, GSBR-1290 demonstrated a clinically meani
$100 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 9.41% on an annualized basis producing an average annual return of 19.79%. Currently, Novo Nordisk has a market capitaliza
Pfizer, Takeda Say Four-year Data Support Adcetris as Hodgkin Lymphoma Treatment
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
On Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli Lilly and Co. (NYSE:LLY).QurAlis has granted Lilly global rights to develop and commercialize QRL-204